Finotonlimab (Anti-PDCD1 / PD-1 / CD279)

Synonyms: SCT-I10A

Finotonlimab (Anti-PDCD1 / PD-1 / CD279) is a recombinant, humanized monoclonal antibody directed against the negative immunoregulatory human cell receptor programmed cell death protein 1 (PD-1, PDCD1, CD279) with potential immune checkpoint inhibitory and antineoplastic activities. MW: 145.38 KD.

Finotonlimab (Anti-PDCD1 / PD-1 / CD279)

Purity & Quality Control

≥99

Choose Selective PD-1/PD-L1 Inhibitors

Biological Activity

Description Finotonlimab (Anti-PDCD1 / PD-1 / CD279) is a recombinant, humanized monoclonal antibody directed against the negative immunoregulatory human cell receptor programmed cell death protein 1 (PD-1, PDCD1, CD279) with potential immune checkpoint inhibitory and antineoplastic activities. MW: 145.38 KD.

Product Details

CAS No. 2350298-85-8
Molecular Weight 145.38
Isotype Human IgG4SP
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac,pH5.0
Storage
(From the date of receipt)
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Finotonlimab (Anti-PDCD1 / PD-1 / CD279) | Finotonlimab (Anti-PDCD1 / PD-1 / CD279) supplier | purchase Finotonlimab (Anti-PDCD1 / PD-1 / CD279) | Finotonlimab (Anti-PDCD1 / PD-1 / CD279) cost | Finotonlimab (Anti-PDCD1 / PD-1 / CD279) manufacturer | order Finotonlimab (Anti-PDCD1 / PD-1 / CD279) | Finotonlimab (Anti-PDCD1 / PD-1 / CD279) distributor